Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for Erectile Dysfunction After Prostate Cancer Radiotherapy
NCT00122499Phase 3Completed
- Sponsor
- Erasmus MC
- Start
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tadalafil in erectile dysfunction (ED) (2 arms), sponsored by Erasmus MC. Primary endpoint: Efficacy of 20 mg tadalafil. Started Feb 2003; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00122499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00122499.